India
· Delayed Price · Currency is INR Jubilant Pharmova Statistics
Total Valuation
Jubilant Pharmova has a market cap or net worth of INR 181.49 billion. The enterprise value is 208.44 billion.
| Market Cap | 181.49B |
| Enterprise Value | 208.44B |
Important Dates
The next estimated earnings date is Friday, October 25, 2024.
| Earnings Date | Oct 25, 2024 |
| Ex-Dividend Date | Aug 2, 2024 |
Share Statistics
Jubilant Pharmova has 158.35 million shares outstanding. The number of shares has decreased by -0.68% in one year.
| Shares Outstanding | 158.35M |
| Shares Change (YoY) | -0.68% |
| Shares Change (QoQ) | +0.02% |
| Owned by Insiders (%) | 7.82% |
| Owned by Institutions (%) | 13.81% |
| Float | 52.60M |
Valuation Ratios
The trailing PE ratio is 32.83 and the forward PE ratio is 31.39. Jubilant Pharmova's PEG ratio is 0.53.
| PE Ratio | 32.83 |
| Forward PE | 31.39 |
| PS Ratio | 2.64 |
| PB Ratio | 3.35 |
| P/FCF Ratio | n/a |
| PEG Ratio | 0.53 |
Enterprise Valuation
| EV / Earnings | 37.71 |
| EV / Sales | 3.04 |
| EV / EBITDA | 20.14 |
| EV / EBIT | 33.33 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.68 |
| Debt / EBITDA | 3.63 |
| Debt / FCF | n/a |
| Interest Coverage | 2.13 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Capital (ROIC) | 4.13% |
| Revenue Per Employee | 12.68M |
| Profits Per Employee | 1.02M |
| Employee Count | 5,399 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +172.05% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +172.05% |
| 50-Day Moving Average | 1,014.15 |
| 200-Day Moving Average | 737.00 |
| Relative Strength Index (RSI) | 55.61 |
| Average Volume (20 Days) | 69,963 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Jubilant Pharmova had revenue of INR 68.48 billion and earned 5.53 billion in profits. Earnings per share was 34.91.
| Revenue | 68.48B |
| Gross Profit | 46.65B |
| Operating Income | 6.00B |
| Pretax Income | 6.45B |
| Net Income | 5.53B |
| EBITDA | 10.09B |
| EBIT | 6.00B |
| Earnings Per Share (EPS) | 34.91 |
Balance Sheet
The company has 9.57 billion in cash and 36.64 billion in debt, giving a net cash position of -27.07 billion or -170.96 per share.
| Cash & Cash Equivalents | 9.57B |
| Total Debt | 36.64B |
| Net Cash | -27.07B |
| Net Cash Per Share | -170.96 |
| Equity (Book Value) | 54.21B |
| Book Value Per Share | 342.17 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 68.13%, with operating and profit margins of 8.76% and 8.07%.
| Gross Margin | 68.13% |
| Operating Margin | 8.76% |
| Pretax Margin | 9.42% |
| Profit Margin | 8.07% |
| EBITDA Margin | 14.74% |
| EBIT Margin | 8.76% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 5.00, which amounts to a dividend yield of 0.44%.
| Dividend Per Share | 5.00 |
| Dividend Yield | 0.44% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.68% |
| Shareholder Yield | 1.12% |
| Earnings Yield | 3.05% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on March 17, 2006. It was a forward split with a ratio of 5.
| Last Split Date | Mar 17, 2006 |
| Split Type | Forward |
| Split Ratio | 5 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |